Related Experiment Video
Updated: Feb 13, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Non-conventional rottlerin anticancer properties
E Maioli1, E Daveri2, E Maellaro3
1Dipartimento di Scienze della Vita, Universita' di Siena, Via A. Moro, 53100, Siena, Italy.
Abstract:
In the past few years, we focused the interest on rottlerin, an old/new natural substance that, over the time, has revealed a number of cellular and molecular targets, all potentially implicated in the fight against cancer. Past and recent literature well demonstrated that rottlerin is an inhibitor of enzymes, transcription factors and signaling molecules that control cancer cell life and death. Although the rottlerin anticancer activity has been mainly ascribed to apoptosis and/or autophagy induction, recent findings unveiled the existence of additional mechanisms of toxicity. The major novelties highlighted in this mini review are the ability to bind and inhibit key molecules, such as ERK and mTOR, directly, thus independently of upstream signaling cascades, and to cause a profound dysregulation of cap-dependent protein translation through the mTORC1/4EBP1/eIF4E axis and by inhibition of eIF2, an initiation factor of translation that is negatively regulated by endoplasmic reticulum (ER) stress. These last mechanisms, proved to be lethal in cancer cell lines derived from breast and skin, strongly enforce the potential of rottlerin as a promising natural lead compound for the development of novel therapeutic approaches.
Insights
Rottlerin, a natural compound, shows promise as an anticancer drug by directly inhibiting key cancer-driving molecules like ERK and mTOR. It also disrupts protein translation, leading to cancer cell death.
Area of Science:
- Natural product chemistry
- Molecular oncology
- Cancer therapeutics
Background:
- Rottlerin is a natural compound with known anticancer properties.
- Its mechanisms of action primarily involve apoptosis and autophagy induction.
- Emerging evidence suggests additional pathways contributing to its toxicity.
Purpose of the Study:
- To review novel anticancer mechanisms of rottlerin.
- To highlight its direct inhibition of ERK and mTOR.
- To explore its impact on protein translation and endoplasmic reticulum stress.
Main Methods:
- Literature review of rottlerin's molecular targets and cellular effects.
- Analysis of studies investigating rottlerin's role in signaling pathways.
- Examination of its effects on protein translation machinery.
Main Results:
- Rottlerin directly inhibits extracellular signal-regulated kinase (ERK) and mechanistic target of rapamycin (mTOR).
- It dysregulates cap-dependent protein translation via the mTORC1/4EBP1/eIF4E axis.
- Rottlerin inhibits eukaryotic initiation factor 2 (eIF2), impacting translation under endoplasmic reticulum stress.
Conclusions:
- Rottlerin exhibits novel anticancer activities beyond apoptosis and autophagy.
- Direct inhibition of ERK and mTOR, alongside protein translation disruption, are key mechanisms.
- Rottlerin represents a promising natural lead compound for developing new cancer therapies.
Related Concept Videos
Sign Convention
The normal force acts perpendicular to the beam's cross-section and can...
Enolate Mechanism Conventions
Dose Response Curve: Conventional Versus Nonmonotonic
Physical and Chemical Properties of Matter
Properties of Transition Metals
General Properties of Solutions

